Company
Zucara Therapeutics
Meeting a critical need to help prevent hypoglycemia in people with diabetes
- Status
- Operatingas of 2026-09-18
- Founded
- 2014
Claim, correct or request removal
Record updated 18 September 2026
About
is developing the first once-daily therapeutic to prevent hypoglycemia (low blood sugar) in people with diabetes.
Funding snapshot
- Total raised
- $46MSum of rounds, as of 2026-09-18Source (opens in a new tab)
- Latest round
- Series B, $25M2025
Funding rounds
- Round, 2025
- $5M2025-02-03, SEC form D sold, 3 investors
- Series B
- $25M2025, Company stated
- Series A
- $21M2020, Company stated
Products
- Other
- ZT-01
Loading relationship preview